A. Moscicki

Epidemiology · American Journal of Clinical Pathology · 2001–2020

A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 53 citations into it
• Surgery — 11 citations into it

Whom A. Moscicki trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Mark Schiffman
2. S. Kjaer

Papers from A. Moscicki's perspective

Ordered by how strongly the researchers A. Moscicki trusts endorse each paper. Same corpus, a different order for every researcher.

1. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical… (American Journal of Clinical Pathology)
2. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. (Obstetrics and Gynecology)
3. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. (Vaccine)
4. What is Cervical Cancer
5. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. (The Lancet Oncology)
6. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. (Journal of the National Cancer Institute. Monographs)
7. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. (The Lancet Oncology)
8. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. (Journal of the National Cancer Institute)
9. Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update (International Journal of Cancer)
10. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. (Lancet. Infectious Diseases (Print))

Their papers

• 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors (2020) — 973 citations
• American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. (2012) — 2,380 citations
• Chapter 5: Updating the natural history of HPV and anogenital cancer. (2006) — 603 citations
• Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. (2006) — 1,626 citations
• American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer (2002) — 893 citations
• Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. (2001) — 606 citations